While KIM-1 shows promise as a biomarker for kidney damage in the context of DCM, more comprehensive research, including studies with larger sample sizes and across different stages of heart and kidney diseases, is needed to establish its diagnostic relevance in canine CKD. This evidence concerns the gene HAVCR1 and Nephropathy.